Skip to content

Clinical trials

Phase 3 Uterine Cervical Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 3 Country / region: Canada Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20063
20072
20093
20112
20122
20161
20181
20202
20211
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting2
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Merck Sharp & Dohme LLC4
National Cancer Institute (NCI)2
Radiation Therapy Oncology Group2
Ciusss de L'Est de l'Île de Montréal1
GOG Foundation1
Gynecologic Oncology Group1
International Atomic Energy Agency1
M.D. Anderson Cancer Center1
NCIC Clinical Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms23
Papillomavirus Infections6
Endometrial Neoplasms2
Appendiceal Neoplasms1
Bile Duct Neoplasms1
Breast Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Ovarian Epithelial1
Colonic Neoplasms1
Condylomata Acuminata1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.